Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tissue fragmentation via ultrasonic cavitation refers to the use of high-frequency ultrasound energy to disrupt biological tissue through the formation, oscillation, and collapse of microbubbles, a phenomenon known as cavitation. These bubbles produce physical forces that fragment tissue at the cellular level, selectively damaging targets like adipocytes in body contouring/liposuction, destroying atherosclerotic plaques, or ablating tumors[1][3][8]. The process is mediated by mechanical (cavitation), thermal (heat), and chemical (free radical generation) effects, with device parameters fine-tuned to target specific tissues while minimizing collateral damage. It is widely used in ultrasonic liposuction, surgical aspirators, and focused ultrasound therapies, but is not a molecular or receptor-based target; it is a physical-chemical method for tissue ablation[5][7][8]. Notable safety concerns include risk of burns, seroma formation, and DNA damage from free radicals[4][7].
Mechanical disruption via cavitation; Cell membrane fragmentation; Implosion of fat cells (adipocytes); Generation of reactive oxygen species (ROS) and free radicals
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tissue fragmentation via ultrasonic cavitation.